Insmed (NASDAQ:INSM – Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.19) by ($0.08), Briefing.com reports. The business had revenue of $93.40 million during the quarter, compared to analysts’ expectations of $93.36 million. The business’s quarterly […]

Eli Lilly and Company (NYSE:LLY – Get Free Report) updated its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 13.020-13.520 for the period, compared to the consensus earnings per share estimate of 13.470. The company issued revenue guidance of $45.4 billion-$46.0 billion, compared to the consensus revenue […]

Zimmer Biomet (NYSE:ZBH – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 7.950-8.050 for the period, compared to the consensus EPS estimate of 7.950. The company issued revenue guidance of $7.7 billion-$7.7 billion, compared to the consensus revenue estimate of $7.7 billion. […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) released its earnings results on Wednesday. The medical research company reported $2.01 EPS for the quarter, beating the consensus estimate of $1.28 by $0.73, Briefing.com reports. The company had revenue of $649.70 million during the quarter, compared to analysts’ expectations of $628.18 million. Bio-Rad Laboratories had a positive […]